IMF Videos Search Content For Healthcare Professional (132) Healthcare Provider (132) Care Partner (67) Patient (67) Series - Any - ASCO/EHA (51) ASH (69) Ask Dr. Durie (23) Black Swan Research Initiative (2) Emerging Therapies (3) Facebook Live (6) IMWG (4) Living Well with Myeloma (2) Myeloma in a Minute (5) Myeloma Made Simple (5) Myeloma University (4) Patient & Family Webinar (1) Q&A (11) Recent News and Developments (4) Treatments (1) Trending Searches in Myeloma (1) Topics Clinical Trials (184) Financial Considerations (15) Frontline Therapy (81) Health Equity (33) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (68) Lifestyle (47) Mental & Emotional Health (28) Myeloma 101 (54) Myeloma in the News (7) Public Policy & Advocacy (17) Q&A's (41) Recorded Seminars & Workshops (14) Recorded Webinars (23) Relapse/Refractory Myeloma (135) Research Updates (192) Symptom Management (113) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (68) High-Risk Myeloma (45) High-risk Smoldering Myeloma (38) Late Relapse (4–6 Lines of Therapy) (84) MGUS (39) Newly Diagnosed (Pre-Treatment or First Treatment) (63) Smoldering Myeloma (49) Types of Therapy Immunomodulatory drugs (IMiDs) (60) Immunotherapies (CAR T; BiTE, etc.) (100) Monoclonal antibodies (54) Proteasome inhibitors (46) Stem cell transplant (38) Steroids (42) Supportive Care (43) Year Published 2026 (20) 2025 (32) 2024 (52) 2023 (43) 2022 (17) 2021 (12) 2020 (1) 2019 (10) 2018 (2) 2017 (1) 2016 (2) Trusted Voices Dr. Joseph Mikhael (36) Dr. Brian GM Durie (20) Dr. María-Victoria Mateos (7) Dr. Saad Usmani (3) Dr. Shaji Kumar (2) Dr. Sigurður Kristinsson (2) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (1) Donna Catamero, ANP-BC, OCN, CCRC (1) Dr. Sagar Lonial (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance CAR T-Cell Therapy Explained in Under 1 Minute | Multiple Myeloma Treatment Breakthroughs April 16, 2025 Myeloma in a Minute Q&A: Ask Me Anything About Myeloma with Dr. Saad Usmani March 10, 2025 Facebook Live Smoldering Myeloma, Bone Marrow Failure & T-Cell Therapy – Dr. Joe Answers Your Myeloma Questions March 6, 2025 Q&A Q&A | Hope for High-Risk Multiple Myeloma: Latest Treatments & Life Expectancy Insights February 13, 2025 Q&A IMWG Conference Series: Making Sense of Treatment ASH 2024 December 18, 2024 IMWG Replay: Discover the Latest Myeloma Research at ASH — Insights for Patients & Families December 12, 2024 Facebook Live How to Find a Multiple Myeloma Clinical Trial in a Minute or Less November 25, 2024 Myeloma in a Minute What is Immunotherapy for Multiple Myeloma? Understanding Its Role in Treatment September 12, 2024 Trending Searches in Myeloma Key Multiple Myeloma Abstracts Presented at 2024 ASCO and EHA Meeting August 1, 2024 ASCO/EHA Evaluation of elranatamab vs EPd, PVd, or Kd in patients with relapsed or refractory multiple myeloma and prior anti-CD38–directed therapy: MagnetisMM-32 July 31, 2024 ASCO/EHA MagnetisMM-30, a Phase 1b Study of ELRA and IBER Combination in Relapsed Refractory Multiple Myeloma July 15, 2024 ASCO/EHA DREAMM-7: Belamaf+BVd vs DVd in RRMM, subgroup analyses of phase 3 trial comparing regimens after relapse July 12, 2024 ASCO/EHA Load More
